EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase–Positive ST131 Escherichia coli to Carbapenem Exposure

William C Shropshire iD, Xinhao Song iD, Jordan Bremer, Seokju Seo iD, Susana Rodriguez iD, Selvalakshmi Selvaraj Anand, An Q Dinh, Micah M Bhatti iD, Anna Konovalova iD, Cesar A Arias, Awdhesh Kalia iD, Yousif Shamoo iD und 1 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von William C Shropshire und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Center. Hauptthemen laut MEDLINE: Carbapenems, beta-Lactamases, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unclear how high-risk Escherichia coli lineages, like sequence type (ST) 131, initially adapt to carbapenem exposure in their progression to carbapenem resistance.

Methods

Carbapenem mutation frequency was measured in multiple subclades of extended-spectrum β-lactamase (ESBL)–positive ST131 clinical isolates using a fluctuation assay followed by whole genome sequencing (WGS) characterization. Genomic, transcriptomic, and porin analyses of the ST131 C2/H30Rx isolate MB1860, under prolonged, increasing carbapenem exposure was performed using 2 experimental evolutionary platforms to measure fast versus slow adaptation.

Results

All 13 ESBL-positive ST131 strains selected from a diverse (n = 184) ST131 bacteremia cohort had detectable ertapenem (ETP) mutational frequencies, with a positive correlation between initial ESBL gene copy number and mutation frequency (r = 0.87, P < 1e-5). WGS analysis of mutants showed that initial response to ETP exposure resulted in significant increases in ESBL gene copy numbers or mutations in Omp genes in the absence of ESBL gene amplification with subclade-specific associations. In both experimental evolutionary platforms, MB1860 responded to initial ETP exposure by increasing blaCTX-M-15 copy numbers via modular, IS26-mediated pseudocompound transposons (PCTns). Increased transcript level of genes present within the PCTn was a conserved expression signal in both experimental evolutionary platforms. Stable mutations in Omp encoding genes were detected only after prolonged increasing carbapenem exposure, consistent with clinical observations.

Conclusions

ESBL gene amplification is a conserved response to initial carbapenem exposure, especially within the high-risk ST131 C2/H30Rx subclade. Targeting such amplification could assist with mitigating carbapenem resistance development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenemsbeta-LactamasesEscherichia coliAnti-Bacterial AgentsHumansEscherichia coli InfectionsWhole Genome SequencingMicrobial Sensitivity TestsMutationPorinsMutation RateErtapenemGenome, Bacterial

Stichwörter der Autor:innen

ESBL gene amplificationexperimental evolutionnon-carbapenemase carbapenem resistancepseudo compound transposonsequence type 131

Substanzen

Carbapenemsbeta-LactamasesAnti-Bacterial AgentsPorinsErtapenem

Autor:innen und Institutionen

  • Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Center.
  • Department of Biosciences, Rice University.
  • Department of Microbiology and Molecular Genetics, McGovern Medical School, The University of Texas Health Science Center at Houston.
  • Program in Diagnostic Genetics and Genomics, The University of Texas MD Anderson Cancer Center School of Health Professions.
  • Division of Infectious Diseases and Center for Infectious Diseases Research, Houston Methodist Hospital and Houston Methodist Research Institute.
  • Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston.

ORCID-Profile: William C Shropshire, Xinhao Song, Seokju Seo, Susana Rodriguez, Micah M Bhatti, Anna Konovalova, Awdhesh Kalia, Yousif Shamoo, Samuel A Shelburne

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Shropshire, W. C., Song, X., Bremer, J., Seo, S., Rodriguez, S., Selvaraj Anand, S., Dinh, A. Q., Bhatti, M. M., Konovalova, A., Arias, C. A., Kalia, A., Shamoo, Y., & Shelburne, S. A. (2025). Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase–Positive ST131 Escherichia coli to Carbapenem Exposure. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae587

Vancouver

Shropshire WC, Song X, Bremer J, Seo S, Rodriguez S, Selvaraj Anand S, et al. Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase–Positive ST131 Escherichia coli to Carbapenem Exposure. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae587

BibTeX
@article{Shropshire2025,
  author = {Shropshire, William C and Song, Xinhao and Bremer, Jordan and Seo, Seokju and Rodriguez, Susana and Selvaraj Anand, Selvalakshmi and Dinh, An Q and Bhatti, Micah M and Konovalova, Anna and Arias, Cesar A and Kalia, Awdhesh and Shamoo, Yousif and Shelburne, Samuel A},
  title = {Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase–Positive ST131 Escherichia coli to Carbapenem Exposure},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae587}
}
Kostenlos starten →